March 13, 2018 | Denise Heady
Fourteen years ago, neurosurgeon and scientist Rahul Jandial, M.D., Ph.D., began to travel to underserved countries to perform brain surgeries on disadvantaged children.
Six Lessons from Behind the Scenes at City of Hope’s CAR T Cell Program
April 2, 2018 | Wayne Lewis
Often unrecognized are the countless folks who work in the spaces between the lab and the clinic — people responsible for doing everything from manufacturing CAR T cells to gaining federal approval for new trials.
On World Cancer Day: Five ways City of Hope physicians, researchers are finding new ways to treat cancer
February 2, 2018 | Denise Heady
Sunday, February 4, is World Cancer Day. Here, we’ve spotlighted how teams at City of Hope are improving the care and treatment of patients diagnosed with cancer everywhere.
Larry Kwak, M.D., Ph.D., Receives Grant for Promising Lymphoma Work
January 12, 2018 | Letisia Marquez
Larry Kwak, M.D., Ph.D., received a grant to support his work with mantle cell lymphoma from the Leukemia & Lymphoma Society, the world’s largest voluntary health organization dedicated to fighting blood cancer.
City of Hope Physicians Announce New CAR T Breakthroughs at Annual ASH Meeting
December 14, 2017 | Letisia Marquez
New blood cancer breakthroughs – including several involving CAR T cell therapy – were announced by City of Hope physicians at the American Society of Hematology (ASH) annual meeting in Atlanta.
Combination Immunotherapy Shown to Be Effective Initial Treatment for Relapsed or Refractory Hodgkin Lymphoma
December 11, 2017 | Katie Neith
Researchers led by Alex Herrera, M.D. have found that a combination of two immunotherapy drugs may be a more tolerable way for patients to fight the disease before a transplant.
Advanced Lung Cancer Patient: ‘I’m Not About to Go Quietly into the Night’
November 30, 2017 | Julia F.
Julie F., 59, of Wisconsin, survived advanced small cell lung cancer after 29 rounds of chemotherapy, five weeks of radiation and experimental immunotherapy. This is her story.